Verona Pharma News

Merck & Co. Makes a Bold Move: Acquiring Verona Pharma for $10 Billion to Expand Its Biopharmaceutical Portfolio

Merck & Co., Inc. has confirmed its $10 billion acquisition of Verona Pharma, aiming to bolster its biopharmaceutical offerings with Verona's COPD treatment, Ohtuvayre. The deal, e...

Merck's Bold $10B Move: Verona Pharma Shares Soar 18% on Takeover Buzz

Verona Pharma's shares surged 18% following reports of a $10 billion takeover bid by Merck & Co., Inc., offering a 23% premium per share. This move aims to strengthen Merck's posit...